Categories: Uncategorized

Toshiba Launches Car Audio Current-Feedback Power Amplifier IC with Built-In Full-Time Offset Detection

Toshiba Corporation’s (TOKYO: 6502) Storage & Electronic Devices Solutions Company today announced the launch of “TCB502HQ,” a 4-channel power amplifier IC that detects output offset voltage, a factor in speaker burnout. Mass production starts today.

The new IC integrates a newly developed, full-time offset detection circuit that detects output offset voltage even during sound reproduction, preventing speaker burnout.

Manufacturers constantly seek to respond to consumer demand by refining the sound quality of car audio and the new IC supports this with integration of a current-feedback system like that found in high-end hi-fi audio. This prevents sound quality degradation at wide bandwidths and secures consistent sound quality.

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

19 hours ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

20 hours ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

20 hours ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

20 hours ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

4 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

4 days ago